期刊文献+

HL-60细胞Nucleostemin表达下调对PI3K/AKT/mTOR通路相关分子的影响 被引量:3

Down-Regulatory Effect of Nucleostemin Expression on Signal Molecule of PI3K/AKT/mTOR Pathway in HL-60 Cells
下载PDF
导出
摘要 本研究旨在探讨白血病细胞中nucleostemin(NS)基因下调对其非依赖p53通路的候选途径PI3K/AKT/mTOR的相关分子表达的影响。通过重组慢病毒表达载体NS-RNAi-GV248转染至p53缺失型HL-60细胞以干扰NS基因的表达。用Real-time PCR技术评价转染后HL-60细胞NS基因的表达情况并检测干扰前后PI3K/AKT/mTOR信号通路中相关分子水平表达的变化。结果表明:重组慢病毒载体NS-RNAi-GV248成功感染了HL-60细胞,在荧光显微镜下可见GFP荧光水平较高,大于80%。Real-time PCR结果显示,NS基因mRNA的抑制率在HL-60细胞中为56.5%;干扰NS的表达后PI3K、AKT和GβL基因mRNA表达量分别为0.491±0.084、0.398±0.164、0.472±0.097,下调明显,与空白对照组(分别为1.002±0.171、1.000±0.411、1.001±0.206)比较差异有统计学意义(P<0.05)。结论:在HL-60细胞中PI3K/AKT/mTOR通路相关分子的变化与NS基因的下调呈正相关,两者的关联性为证明PI3K/AKT/mTOR信号通路可能是NS的一种非依赖p53作用途径提供了依据。 This study was purposed to explore the down-regulatory effect of nucleostemin(NS) expression on signal molecules of PI3K/AKT/mTOR pathway belonged to candidate ways of p53-independent signal pathway in the leukemia cells.The expression of NS was interfered by using recombinant lentivirus expression vector NS-RNAi-GV248 to transfect HL-60 cells of p53 deficiency.The exression of NS and signal molecules of PI3K/AKT/mTOR pathway were detected by using Real-time PCR.The results of showed that the HL-60 cells were transfected by recombinant lentivirus vector NS-RNAi-GV248 successfully and with transfection rate up to 80%.According to results of Real-time PCR detection,the inhibition rate of NS gene was 56.5% in HL-60 cells.And the expression levels of PI3K,AKT and GβL mRNA (0.491 ± 0.084、0.398 ± 0.164、0.472 ± 0.097 respectively) were obviously down-regulated by silencing NS,and showed statistical difference(P < 0.05) in comparison with control (1.002 ± 0.171、1.000 ± 0.411、1.001 ± 0.206 respectively).It is concluded that the changes of signal molecules of PI3K/AKT/mTOR pathway positively correlate with NS down-regulation,which provides evidence for confirming PI3K/AKT/mTOR signal pathway possible as a type of NS p53-independent pathway.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2014年第1期25-29,共5页 Journal of Experimental Hematology
基金 国家自然科学基金(81271911) 河南省医学科技攻关重点项目(201002006)资助
关键词 NUCLEOSTEMIN PI3K AKT MTOR信号通路 HL-60细胞 p53缺失型 nucleostemin PI3 K/AKT/mTOR pathway HL-60 cell p53 deficiency
  • 相关文献

参考文献5

二级参考文献24

共引文献75

同被引文献31

  • 1钱晖,许文荣,王文兵,韩崇旭,郝顺祖,朱伟,孙晓春,胡嘉波,黄诒森.骨髓间充质干细胞和部分肿瘤细胞中Nucleostemin基因的表达[J].中国生物化学与分子生物学报,2005,21(1):8-12. 被引量:36
  • 2蔡子微,刘思金,孙丽秋,劳为德.Nucleostemin特异性RNA干扰对HeLa细胞体内外增殖能力的影响[J].中国病理生理杂志,2005,21(7):1331-1335. 被引量:14
  • 3蔡子微,郑学芝,胡静.乳腺肿瘤组织nucleostemin基因表达与临床病理表现的关系[J].中国病理生理杂志,2007,23(11):2191-2194. 被引量:13
  • 4Xu W,Qian H, Zhu W, et al. A novel tumor cell line cloned from mutated human embryonic bone marrow mesenchymal stem ceils [J]. Oncol Rep,2004,12(3) :501 508.
  • 5He TC,Zhou S,da Costa LT, et al. A simplified system for gen- erating recombinant adenovirusesJ]. Proe Natl Acad Sei U S A, 1998,95(5) :2509-2514.
  • 6Raoof M, Yaghoobi MM, Derakhshani A, et al. A modified effi- cient method for dental pulp stem cell isolation[J]. Dent Res J (Isfahan), 2014,11 (2) : 244-250.
  • 7Zia Jahromi N, Hejazi SH, Panjepour M, et al. Comparison of nu cleostemin gene expression in CD133 and CD133- cell popula tion in colon cancer cell line HT29[J]. J Cancer Res Ther,2014, 10(1) :68-72.
  • 8Ouo Y, Liao YP, Zhang D, et al. In vitro Study of Nucleostemin as a Potential Therapeutic Target in Human Breast Carcinoma SKBR-3 Cells[J]. Asian Pac J Cancer Prey, 2014,15 (5) : 2291- 2295.
  • 9Seyed Gogani N, Rahmati M, Zarghami N, et al. Ucleostemin de- pletion induces post-g1 arrest apoptosis in chronic myelogenous leukemia k562 cells[J]. Adv Pharm Bu11,2014,4(1) :55-60.
  • 10Sun X,Jia Y, Wei Y, et al. Gene expression profiling of HL-60 cells following knockdown of nucIeostemin using DNA microar- rays[J]. Oncol Rep, 2014,32 (2) : 739-747.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部